Transfection by Electroporation
Authors:
Open Access
- 3 April 2017
- journal article
- unit
- Published by Wiley in Current Protocols in Immunology
- Vol. 117 (1) , 10.15.1-10.15.9
Abstract
Electroporation—the use of high‐voltage electric shocks to introduce DNA into cells—can be used with most cell types, yields a high frequency of both stable transformation and transient gene expression, and, because it requires fewer steps, can be easier than alternative techniques. This unit describes electroporation of mammalian cells, including ES cells, for the preparation of knock‐out, knock‐in, and transgenic mice. Protocols are described for the use of electroporation in vivo to perform gene therapy for cancer, as well as for DNA vaccination. © 2017 by John Wiley & Sons, Inc.Keywords
This publication has 23 references indexed in Scilit:
- Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical DevelopmentsMolecular Therapy, 2009
- Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrodeGene Therapy, 2006
- Isotopic Assays for Reporter Gene ActivityCurrent Protocols in Molecular Biology, 2001
- Calcium Phosphate TransfectionCurrent Protocols in Immunology, 1999
- Preparation of Bacterial Plasmid DNACurrent Protocols in Immunology, 1998
- Production of Mouse T Cell HybridomasCurrent Protocols in Immunology, 1997
- Nonisotopic Assays for Reporter Gene ActivityCurrent Protocols in Molecular Biology, 1995
- Stable Transfer of Genes into Mammalian CellsCurrent Protocols in Immunology, 1994
- Purification and Concentration of DNA from Aqueous SolutionsCurrent Protocols in Immunology, 1993
- Transfection Using DEAE ‐DextranCurrent Protocols in Immunology, 1992